Analyzing the mechanism of Rap1 activation in platelets: Rap1 activation is related to the release reaction mediated through the collagen receptor GPVI

Stephanie M. Jung, Masaaki Ohnuma, Naohide Watanabe, Mamiko Sonoda, Makoto Handa, Masaaki Moroi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The abundant Rap1 in platelets becomes activated when these cells are stimulated by various agonists, but its function has remained unknown. In view of this, we developed an assay to quantitatively measure activated Rap1 and used it to determine relationships between Rap1 activation and several platelet functions: integrin α2β1 activation, tyrosine phosphorylation, and the release reaction. We looked at how these processes are affected by the protein kinase C inhibitor BIMI, tyrosine kinase inhibitor PP2, PI 3-kinase inhibitor wortmannin, and ADP scavenger apyrase. In CRP (collagen related peptide)-activated platelets, all the inhibitors severely inhibited Rap1 activation, but had little effect on integrin α2β1 activation, indicating that the integrin activation mechanism is different from the Rap1 activation mechanism, at least in GPVI-dependent activation. With p85α-null mouse platelets, we demonstrated that Rap1 activation involves PI 3-kinase p85α-dependent tyrosine phosphorylation. All the inhibitors similarly decreased Rap1 activation and the serotonin release reaction, and the inhibition of Rap1 activation was not due to the lack of released ADP. Our results indicate that platelet Rap1 activation is closely related to the release reaction and not to integrin α2β1 activation in GPVI-mediated platelet activation.

Original languageEnglish
Pages (from-to)509-521
Number of pages13
JournalThrombosis Research
Volume118
Issue number4
DOIs
Publication statusPublished - 2006

Fingerprint

Platelet Activation
Integrins
Phosphatidylinositol 3-Kinases
Adenosine Diphosphate
Tyrosine
Blood Platelets
Phosphorylation
Apyrase
Protein C Inhibitor
Platelet Aggregation Inhibitors
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Protein Kinase C
Serotonin
platelet membrane glycoprotein VI

Keywords

  • GPVI
  • Integrin activation
  • Platelets
  • Rap1
  • Release reaction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

Analyzing the mechanism of Rap1 activation in platelets : Rap1 activation is related to the release reaction mediated through the collagen receptor GPVI. / Jung, Stephanie M.; Ohnuma, Masaaki; Watanabe, Naohide; Sonoda, Mamiko; Handa, Makoto; Moroi, Masaaki.

In: Thrombosis Research, Vol. 118, No. 4, 2006, p. 509-521.

Research output: Contribution to journalArticle

Jung, Stephanie M. ; Ohnuma, Masaaki ; Watanabe, Naohide ; Sonoda, Mamiko ; Handa, Makoto ; Moroi, Masaaki. / Analyzing the mechanism of Rap1 activation in platelets : Rap1 activation is related to the release reaction mediated through the collagen receptor GPVI. In: Thrombosis Research. 2006 ; Vol. 118, No. 4. pp. 509-521.
@article{c21eaa0553c84d09959f1ac6ccf606e8,
title = "Analyzing the mechanism of Rap1 activation in platelets: Rap1 activation is related to the release reaction mediated through the collagen receptor GPVI",
abstract = "The abundant Rap1 in platelets becomes activated when these cells are stimulated by various agonists, but its function has remained unknown. In view of this, we developed an assay to quantitatively measure activated Rap1 and used it to determine relationships between Rap1 activation and several platelet functions: integrin α2β1 activation, tyrosine phosphorylation, and the release reaction. We looked at how these processes are affected by the protein kinase C inhibitor BIMI, tyrosine kinase inhibitor PP2, PI 3-kinase inhibitor wortmannin, and ADP scavenger apyrase. In CRP (collagen related peptide)-activated platelets, all the inhibitors severely inhibited Rap1 activation, but had little effect on integrin α2β1 activation, indicating that the integrin activation mechanism is different from the Rap1 activation mechanism, at least in GPVI-dependent activation. With p85α-null mouse platelets, we demonstrated that Rap1 activation involves PI 3-kinase p85α-dependent tyrosine phosphorylation. All the inhibitors similarly decreased Rap1 activation and the serotonin release reaction, and the inhibition of Rap1 activation was not due to the lack of released ADP. Our results indicate that platelet Rap1 activation is closely related to the release reaction and not to integrin α2β1 activation in GPVI-mediated platelet activation.",
keywords = "GPVI, Integrin activation, Platelets, Rap1, Release reaction",
author = "Jung, {Stephanie M.} and Masaaki Ohnuma and Naohide Watanabe and Mamiko Sonoda and Makoto Handa and Masaaki Moroi",
year = "2006",
doi = "10.1016/j.thromres.2005.11.002",
language = "English",
volume = "118",
pages = "509--521",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Analyzing the mechanism of Rap1 activation in platelets

T2 - Rap1 activation is related to the release reaction mediated through the collagen receptor GPVI

AU - Jung, Stephanie M.

AU - Ohnuma, Masaaki

AU - Watanabe, Naohide

AU - Sonoda, Mamiko

AU - Handa, Makoto

AU - Moroi, Masaaki

PY - 2006

Y1 - 2006

N2 - The abundant Rap1 in platelets becomes activated when these cells are stimulated by various agonists, but its function has remained unknown. In view of this, we developed an assay to quantitatively measure activated Rap1 and used it to determine relationships between Rap1 activation and several platelet functions: integrin α2β1 activation, tyrosine phosphorylation, and the release reaction. We looked at how these processes are affected by the protein kinase C inhibitor BIMI, tyrosine kinase inhibitor PP2, PI 3-kinase inhibitor wortmannin, and ADP scavenger apyrase. In CRP (collagen related peptide)-activated platelets, all the inhibitors severely inhibited Rap1 activation, but had little effect on integrin α2β1 activation, indicating that the integrin activation mechanism is different from the Rap1 activation mechanism, at least in GPVI-dependent activation. With p85α-null mouse platelets, we demonstrated that Rap1 activation involves PI 3-kinase p85α-dependent tyrosine phosphorylation. All the inhibitors similarly decreased Rap1 activation and the serotonin release reaction, and the inhibition of Rap1 activation was not due to the lack of released ADP. Our results indicate that platelet Rap1 activation is closely related to the release reaction and not to integrin α2β1 activation in GPVI-mediated platelet activation.

AB - The abundant Rap1 in platelets becomes activated when these cells are stimulated by various agonists, but its function has remained unknown. In view of this, we developed an assay to quantitatively measure activated Rap1 and used it to determine relationships between Rap1 activation and several platelet functions: integrin α2β1 activation, tyrosine phosphorylation, and the release reaction. We looked at how these processes are affected by the protein kinase C inhibitor BIMI, tyrosine kinase inhibitor PP2, PI 3-kinase inhibitor wortmannin, and ADP scavenger apyrase. In CRP (collagen related peptide)-activated platelets, all the inhibitors severely inhibited Rap1 activation, but had little effect on integrin α2β1 activation, indicating that the integrin activation mechanism is different from the Rap1 activation mechanism, at least in GPVI-dependent activation. With p85α-null mouse platelets, we demonstrated that Rap1 activation involves PI 3-kinase p85α-dependent tyrosine phosphorylation. All the inhibitors similarly decreased Rap1 activation and the serotonin release reaction, and the inhibition of Rap1 activation was not due to the lack of released ADP. Our results indicate that platelet Rap1 activation is closely related to the release reaction and not to integrin α2β1 activation in GPVI-mediated platelet activation.

KW - GPVI

KW - Integrin activation

KW - Platelets

KW - Rap1

KW - Release reaction

UR - http://www.scopus.com/inward/record.url?scp=33747872565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747872565&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2005.11.002

DO - 10.1016/j.thromres.2005.11.002

M3 - Article

C2 - 16380154

AN - SCOPUS:33747872565

VL - 118

SP - 509

EP - 521

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 4

ER -